ArticleJournal of gastrointestinal oncology2024

The benefit of adjuvant chemotherapy in pathological T1-3N0M0 rectal mucinous adenocarcinoma: no improvement survival outcomes based on long-term survival analysis of large population data.

Hualin Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.